Associated Banc Corp Rhythm Pharmaceuticals, Inc. Transaction History
Associated Banc Corp
- $3.64 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding RYTM
# of Institutions
271Shares Held
67.6MCall Options Held
248KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$673 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$560 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$555 Million7.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$499 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.26MShares$426 Million0.34% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.56B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...